# Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA

> **NCT00680043** · PHASE2 · COMPLETED · sponsor: **Affymax** · enrollment: 114 (actual)

## Conditions studied

- Anemia
- Chronic Renal Failure
- Chronic Kidney Disease

## Interventions

- **DRUG:** peginesatide
- **DRUG:** peginesatide
- **DRUG:** Epoetin Alfa

## Key facts

- **NCT ID:** NCT00680043
- **Lead sponsor:** Affymax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2012-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00680043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00680043, "Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00680043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*